Penserra Capital Management LLC
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1593324
ORINDA, CA
Position in VRTX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$10,431
+$1,054 QoQ
Shares Held
21
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1,630
of 1,735 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Penserra Capital Management LLC holds $16,002,475 across 25 Biotechnology names. VRTX ranks #22 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TVTX |
Travere Therapeutics, Inc.
|
54,216 | $3,080,010 | |
| 2 | AXSM |
Axsome Therapeutics, Inc.
|
11,268 | $2,758,068 | |
| 3 | TGTX |
Tg Therapeutics, Inc.
|
50,017 | $2,747,933 | |
| 4 | KRYS |
Krystal Biotech, Inc.
|
5,142 | $1,911,127 | |
| 5 | BCAX |
Bicara Therapeutics Inc.
|
31,066 | $922,349 | |
| 6 | ELVN |
Enliven Therapeutics, Inc.
|
16,660 | $845,495 | |
| 7 | APGE |
Apogee Therapeutics, Inc.
|
6,300 | $836,199 | |
| 8 | RCUS |
Arcus Biosciences, Inc.
|
26,929 | $830,221 |
All Filings in VRTX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,431 | 21 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $9,377 | 21 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $9,520 | 21 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $8,224 | 21 | Shares | Defined | 2025-11-04 | |
| 2025-06-30 | $9,349 | 21 | Shares | Defined | 2025-08-06 | |
| 2025-03-31 | $61,087 | 126 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $271,419 | 674 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $9,766 | 21 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $9,843 | 21 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $8,778 | 21 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $694,153 | 1,706 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $536,214 | 1,542 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $695,378 | 1,990 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $654,403 | 2,091 | Shares | Defined | 2023-04-24 | |
| 2022-12-31 | $38,695 | 134 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $3,649,651 | 12,605 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $4,423,820 | 15,699 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $5,992,392 | 22,962 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $27,669 | 126 | Shares | Defined | 2022-02-15 | |
| 2021-09-30 | $21,766 | 120 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $18,146 | 90 | Shares | Defined | 2021-08-12 | |
| 2020-12-31 | $1,011,062 | 4,278 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $3,735,391 | 13,727 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $7,519,029 | 25,900 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $321,232 | 1,350 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||